Report cards › Food › Bake Crafters Food Company

Bake Crafters

Owned by Bake Crafters Food Company · 449 products in USDA FoodData Central · as of Oct 29, 2026 · Report an error · Change log

CSWH grade B (84)

Method v1.0 (how we grade), based on the records below; exact score 83.7595.

Grade by indicator
IndicatorGradeWhat we found
Recalls (40%)B (80)1 Class II (4 points) · 1 event For current recalls see FDA and USDA.
Ingredients (40%)B (79)Tier A: 1 of 449 products (Potassium bromate) · A (99) (25%)
Tier B: 143 of 449 products (DATEM, Bleached flour, Potassium iodate, Titanium dioxide, FD&C Red No. 40, Butylated hydroxytoluene (BHT) and 7 more) · D (47) (15%) · products
FDA warning letters (20%)A (100)None found to the owner Oct 29, 2021 to Oct 29, 2026.

Shown, not graded: recall reasons (1 pathogen) · IARC notes (6 products) · FDA dye pledge: none on FDA's tracker.

Recalls, Oct 29, 2021 to Oct 29, 2026

  1. Class II, Dec 28, 2021 · Pathogen · FDA event 89363

    • Bake Crafters - Maple Waffle WG Chicken Sausage Packaged into cardboard containers 126 units per case

      Reason (FDA's words)
      Potential Listeria monocytogenes contamination
      Code information
      Lot Number: 21343 Product Number: 6657 Best By: 12/09/22
      Recalling firm
      Bake Crafters
      Dates
      Recall started Dec 28, 2021; classified Jan 26, 2022
      Status
      Terminated (status reported by FDA at classification)
      How we matched it
      matched by recalling firm (name) and brand name

      FDA record F-0620-2022: openFDA · Report an error

Store-brand and co-packer recalls count on a brand only when a UPC in the recall matches one of its products.

Ingredients on our watch list

Products (148)

Labels change: each row shows the date of its FoodData Central record. A brand that has changed a recipe can report it with "Report an error".

FDA warning letters to Bake Crafters Food Company, Oct 29, 2021 to Oct 29, 2026

None found from FDA food offices.

FDA notes that later events may have changed the regulatory status of what a letter discusses.